Last time we talked with David Muller, PhD, he was leaving Avedro to start a new company. Two years later, Dr. Muller’s company, Allotex, has raised capital from a strategic investor and is preparing to enter clinical trials in Europe. In this OIS Podcast, Muller tells us why Allotex may succeed where others have fallen short. For more on Allotex, watch this Companies to Watch presentation.
Meet Our Host
Joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.